A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease.

Gelijkaardige items

• N-methyl-D-aspartate (NMDA) antagonists in Parkinson's disease.
  door: Kornhuber, J, et al.
  Gepubliceerd in: (1993)
• N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
  door: Olivares, David, et al.
  Gepubliceerd in: (2012)
• Differential action of NMDA antagonists on cholinergic neurotoxicity produced by N-methyl-D-aspartate and quinolinic acid.
  door: Pawley, A. C., et al.
  Gepubliceerd in: (1996)
• Direct Inhibition of N-Methyl-D-Aspartate (NMDA)-Receptor Function by Antiglaucomatous β-Antagonists
  door: Tatsuo Nagata, et al.
  Gepubliceerd in: (2008-01-01)
• Pentamidine is an N-methyl-D-aspartate receptor antagonist and is neuroprotective in vitro
  door: Reynolds, IJ, et al.
  Gepubliceerd in: (1992)